PRIA Logo™
New HampshireHB7012025-2026 Regular SessionHouseWALLET

HB701

Sponsored By: Lisa R Mazur (Republican)

Signed by Governor

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

4 provisions identified: 1 benefits, 0 costs, 3 mixed.

Sue regulators who block access

Beginning January 1, 2026, patients with life‑threatening diseases who have been, are being, or could be treated in New Hampshire can sue in Superior Court for an injunction if regulators or law enforcement violate this chapter. Health care facilities and providers involved in that care can also petition. Courts may award reasonable attorney’s fees. The whole chapter takes effect January 1, 2026.

Easier telehealth screening, with lawsuit limits

Beginning January 1, 2026, a provider who is physically in New Hampshire may prescreen any out‑of‑state patient by telehealth for a life‑threatening disease. The law defines telehealth prescreening as a real‑time remote talk to check trial or treatment access. Regulators and law enforcement cannot take action against covered prescreenings. Providers and facilities are immune from lawsuits that are based only on a qualifying prescreening.

Remote notarized consent for treatment

Beginning January 1, 2026, providers, facilities, or manufacturers with an office in New Hampshire may obtain notarized remote informed consent after a required telehealth prescreening. A patient may sign, or a parent or guardian may sign if the patient is a minor or lacks capacity. The notarized remote signature counts as full legal consent. Regulators cannot act against this, and providers are immune from suits that only challenge the validity of the remote signing if they acted in good faith and without willful misconduct.

Fewer lawsuits over high‑risk treatments

Beginning January 1, 2026, manufacturers, pharmacists, providers, and facilities are immune from some lawsuits over harm from a drug, biologic, or device when strict rules are met. Two doctors must confirm a life‑threatening disease. The treating doctor must find no comparable FDA‑approved option. The patient or a parent or guardian must give written informed consent. There is no immunity for willful misconduct, including conduct meant to hasten death. The chapter does not create new private lawsuits against providers or manufacturers beyond what it expressly allows.

Sponsors & Cosponsors

Sponsor

  • Lisa R Mazur

    Republican • House

Cosponsors

  • Erica J Layon

    Republican • House

  • Henry R Giasson

    Republican • House

  • Jim A Kofalt

    Republican • House

  • Joe H. Alexander

    Republican • House

  • Keith Michael Ammon

    Republican • House

  • Keith R. Murphy

    Republican • Senate

  • Rich M Nalevanko

    Republican • House

  • Sherri L Reinfurt

    Republican • House

  • Victoria Sullivan

    Republican • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Signed by Governor Ayotte 08/20/2025; Chapter 304; eff. 01/01/2026

    8/25/2025House

  2. Enrolled (in recess of) 06/26/2025 HJ 18 P. 63

    7/14/2025House

  3. Enrolled Adopted, VV, (In recess 06/26/2025); SJ 18

    7/14/2025Senate

  4. Conference Committee Report 2025-2834c: Adopted, VV 06/26/2025 HJ 18 P. 18

    6/26/2025House

  5. Conference Committee Report # 2025-2834c, Adopted, VV; 06/26/2025; SJ 17

    6/26/2025Senate

  6. Conference Committee Report Filed, # 2025-2834c; 06/26/2025

    6/19/2025Senate

  7. Conference Committee Meeting: 06/18/2025 10:30 am LOB 206-208

    6/18/2025House

  8. Conference Committee Meeting: 06/17/2025 02:00 pm LOB 305

    6/17/2025House

  9. Conferee Change: Rep. Lucas Replaces Rep. Lamontagne 06/16/2025 HJ 17 P. 24

    6/16/2025House

  10. Conference Committee Meeting: 06/16/2025 02:00 pm LOB 202-204

    6/16/2025House

  11. Speaker Appoints: Reps. W. MacDonald, Layon, Kesselring, LaMontagne 06/05/2025 HJ 16 P. 168

    6/11/2025House

  12. President Appoints: Senators Rochefort, Abbas, Prentiss; (In Recess 06/05/2025); SJ 16

    6/11/2025Senate

  13. Sen. Rochefort Accedes to House Request for Committee of Conference, MA, VV; (In recess 06/05/2025); SJ 16

    6/11/2025Senate

  14. House Non-Concurs with Senate Amendment 2025-1986s and 2025-2579s and Requests CofC (Rep. Kofalt): MA VV 06/05/2025 HJ 16 P. 168

    6/10/2025House

  15. Ought to Pass with Amendments #2025-1986s and #2025-2579s, MA, VV; OT3rdg; 06/05/2025; SJ 15

    6/5/2025Senate

  16. Sen. Birdsell Floor Amendment # 2025-2579s, AA, VV; 06/05/2025; SJ 15

    6/5/2025Senate

  17. Committee Amendment # 2025-1986s, AA, VV; 06/05/2025; SJ 15

    6/5/2025Senate

  18. Without Objection, the Clerk is authorized to make technical and administrative corrections which are necessary to reflect the intent of the Senate, MA; 06/05/2025; SJ 15

    6/5/2025Senate

  19. Committee Report: Ought to Pass with Amendment # 2025-1986s, 05/15/2025, Vote 5-0; SC 21

    5/15/2025Senate

  20. Committee Report: Ought to Pass with Amendment # 2025-1986s, 06/05/2025, Vote 5-0; SC 22

    5/15/2025Senate

  21. Special Order to 06/05/2025, Without Objection, MA; 05/15/2025 SJ 13

    5/15/2025Senate

  22. ==ROOM CHANGE== Hearing: 04/23/2025, Room 103, SH, 09:15 am; SC 18

    4/16/2025Senate

  23. Hearing: 04/23/2025, Room 101, LOB, 10:00 am; SC 18

    4/14/2025Senate

  24. Introduced 03/27/2025 and Referred to Health and Human Services; SJ 10

    3/28/2025Senate

  25. Ought to Pass with Amendment 2025-0967h: MA VV 03/26/2025 HJ 10 P. 33

    3/26/2025House

Bill Text

  • Enrolled

    7/14/2025

    HTML

  • Introduced

    1/21/2025

    PDF

  • CHAPTERED FINAL VERSION

    PDF

  • Version adopted by both bodies

    PDF

Related Bills

Back to State Legislation